1. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Gaia Palmini et al, 2017, Molecules CrossRef
  2. miR‑205‑5p inhibits cell migration and invasion in prostatic carcinoma by targeting ZEB1
    Lianpeng Li et al, 2018, Oncology Letters CrossRef
  3. Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy
    Sama Izadpanah et al, 2019, Biomedicine & Pharmacotherapy CrossRef

  4. circPVT1 Facilitates Invasion and Metastasis by Regulating miR-205-5p/c-FLIP Axis in Osteosarcoma


    Yu-Peng Liu et al, 2020, Cancer Management and Research CrossRef
  5. Runx2 expression: A mesenchymal stem marker for cancer
    Maria Teresa Valenti et al, 2016, Oncology Letters CrossRef
  6. Long noncoding RNA MALAT1 promotes cell proliferation through suppressing miR-205 and promoting SMAD4 expression in osteosarcoma
    Qingbo Li et al, 2017, Oncotarget CrossRef
  7. MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2
    Yuanlong Xie et al, 2017, Scientific Reports CrossRef
  8. miR-205-5p inhibits thymic epithelial cell proliferation via FA2H-TFAP2A feedback regulation in age-associated thymus involution
    Bishuang Gong et al, 2020, Molecular Immunology CrossRef
  9. LncRNA HCG18 Promotes Osteosarcoma Cells Proliferation, Migration, and Invasion in by Regulating miR-34a/RUNX2 Pathway
    Yi-Ping Chen et al, 2023, Biochemical Genetics CrossRef
  10. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma
    Zuo-Wei Shi et al, 2016, Cancer Biomarkers CrossRef
  11. Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks
    Zhimin Yang et al, 2022, Cell Cycle CrossRef
  12. MicroRNA‑638 expression change in osteosarcoma patients via PLD1 and VEGF expression
    Min Xue et al, 2019, Experimental and Therapeutic Medicine CrossRef
  13. The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis
    Francisco Villanueva et al, 2019, Journal of Cellular Physiology CrossRef
  14. Prostate cancer cell‑derived spondin 2 boosts osteogenic factor levels in osteoblasts via the PI3K/AKT/mTOR pathway
    Hongbo Wang et al, 2022, Oncology Reports CrossRef
  15. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef
  16. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma
    Fernando Alegre et al, 2020, Veterinary and Comparative Oncology CrossRef
  17. MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer
    Eva Karamitopoulou et al, 2017, Modern Pathology CrossRef
  18. Retraction: Methylation-induced downregulation and tumor suppressive role of microRNA-29b in gastric cancer through targeting LASP1
    Hui Li et al, 2023, Oncotarget CrossRef
  19. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma
    Yiqi Deng et al, 2018, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  20. Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?
    Claudia Maria Hattinger et al, 2018, Expert Review of Molecular Diagnostics CrossRef
  21. RUNX2 as a promising therapeutic target for malignant tumors
    Weizhu Zhao et al, 2021, Cancer Management and Research CrossRef